Bosch Q3 net up 16 pc at Rs 158 cr
Auto component maker Bosch today posted a net profit of Rs 158.20 crore for the third quarter ended September 30,a growth of 15.67 per cent from that in the corresponding period a year ago.
More: continued here
Auto component maker Bosch today posted a net profit of Rs 158.20 crore for the third quarter ended September 30,a growth of 15.67 per cent from that in the corresponding period a year ago.
More: continued here
Australian team was 338 for 4 all thanks to some obdurate batting by their top-order which kept the Indian attack at bay.
More: continued here
Archived under TOP STORIES Comments
Two-time champion Spaniard Fernando Alonso of Renault said Thursday that he had no hard feelings towards Lewis Hamilton, but still wanted his rival Felipe Massa to take the world title.
More: continued here
Scientists have designed a sensitive prototype to test dozens of diseases simultaneously by scanning a card loaded with microscopic blood, saliva or urine samples.
More: continued here
The city-based UCO Bank registered a net profit of Rs.1.5 billion in the quarter ended Sep 30, compared to Rs.1.1 billion during the corresponding period last fiscal, a top company official said
More: continued here
Raj Thackeray said he was not opposed to ‘Chhat’ puja but warned against it being used as a show of political strength.
More: continued here
Archived under TOP STORIES Comments
The inaugural All India Police badminton championship began here today in the presence of Uttarakhand Chief Minister B C Khanduri.
More: continued here
Public sector lender Andhra Bank today said its net profit for the second quarter ended September 30 grew by 7 per cent at Rs 161.53 crore over the corresponding period a year ago.
More: continued here
India’s top shuttlers posted contrasting victories en route to the quarterfinals of the Yonex Sunrise-BWF World Junior Badminton Championship at the Balewadi Sports Complex Pune on Thursday.
More: continued here
Meet the flip side of a concern about corporate influence in the doctor’s office - when the pharmaceutical industry entices them to prescribe brand-name drugs.
More: continued here